(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

AMERICAN SOCIETY OF CLINICAL ONCOLOGY

ST13

US500000076175749

Class

41, 42

Filing

76175749

Registration

2778915

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

07/09/2023

Trademark type

Word

Nice classes

41, 42

Filing date

12/05/2000

Registration date

11/04/2003

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/09/2023

Last transaction

07/09/2023

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

1964-11-00

First use in commerce

1964-11-00

Drawing code

1

Owner type

99

Owner location

Alexandria, VA

Examiner

WILLIS, PAMELA Y

Law office

L60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

American Society of Clinical Oncology, Inc.

Representatives

Emilia F. Cannella ROPES & GRAY LLP

Technical classification

Nice Classes

Class 41Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

educational servicesnamely conducting seminars in the field of medical care of patients with cancer

Class 42

medical researchpatient-oriented research in the field of cancer

Publications

History of USPTO decisions and trademark events.

37 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

07/09/2023

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

07/09/2023

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

07/09/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/09/2023

E89R

TEAS SECTION 8 & 9 RECEIVED

12/14/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/04/2022

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/23/2013

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

10/23/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/23/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/23/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

10/18/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

10/18/2013

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

09/04/2012

ES7R

TEAS SECTION 7 REQUEST RECEIVED

08/24/2012

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/31/2009

E815

TEAS SECTION 8 & 15 RECEIVED

01/15/2009

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/12/2008

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/12/2008

CFIT

CASE FILE IN TICRS

02/20/2008

CORV

REVIEW OF CORRESPONDENCE COMPLETE

09/06/2006

MAIL

PAPER RECEIVED

01/23/2004

R.PR

REGISTERED-PRINCIPAL REGISTER

11/04/2003

PUBO

PUBLISHED FOR OPPOSITION

08/12/2003

NPUB

NOTICE OF PUBLICATION

07/23/2003

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/16/2003

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/29/2003

MAIL

PAPER RECEIVED

05/29/2003

CNRT

NON-FINAL ACTION MAILED

01/28/2003

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

01/28/2003

IUCN

NOTICE OF ALLOWANCE CANCELLED

07/20/2002

NOAM

NOA MAILED - SOU REQUIRED FROM APPLICANT

05/14/2002

PUBO

PUBLISHED FOR OPPOSITION

02/19/2002

NPUB

NOTICE OF PUBLICATION

01/30/2002

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/26/2001

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2001

CNRT

NON-FINAL ACTION MAILED

04/13/2001

DOCK

ASSIGNED TO EXAMINER

04/12/2001

Continuous trademark protection

Get notified about every new filing that threatens AMERICAN SOCIETY OF CLINICAL ONCOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.